We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.91B
1-Year Est. Return 44.39%
This Fund
S&P 500
This Quarter Est. Return
+13.16%
1 Year Est. Return
+44.39%
3 Year Est. Return
+110.36%
5 Year Est. Return
+52.4%
10 Year Est. Return
+1,142.23%
AUM
$548M
AUM Growth
+$35.5M
Cap. Flow
-$7.48M
Cap. Flow %
-1.37%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
LCTX icon
Lineage Cell Therapeutics
LCTX
+$10.1M

Top Sells

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$17.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 47.51%
2 Healthcare 31.76%
3 Consumer Staples 20.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOR
1
DELISTED
QUESTCOR PHARMA INC
QCOR
$189M 34.55%
2,046,660
-205,000
-9% -$17.6M
STAA icon
2
STAAR Surgical
STAA
$1.14B
$116M 21.12%
6,887,095
– –
MNST icon
3
Monster Beverage
MNST
$87.5B
$114M 20.73%
19,189,632
– –
MNST icon
4
PUT
Monster Beverage
MNST
$87.5B
$71M 12.96%
12,000,000
– –
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$263M
$40.9M 7.47%
16,630,344
+4,460,444
+37% +$10.1M
CYNO
6
DELISTED
Cynosure, Inc. Class A
CYNO
$17.4M 3.17%
817,029
– –

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.91B AUM 19.99% 1-Year Est. Return
RMA
Roffman Miller Associates Philadelphia, Pennsylvania $1.91B AUM 28.29% 1-Year Est. Return
LWMT
Legacy Wealth Management (Tennessee) Memphis, Tennessee $1.91B AUM 17.42% 1-Year Est. Return
FIB
First Interstate Bank Billings, Montana $1.92B AUM 19.65% 1-Year Est. Return
SAM
Southeastern Asset Management Memphis, Tennessee $1.92B AUM 6.41% 1-Year Est. Return
HPC
Hill Path Capital New York $1.92B AUM 5.67% 1-Year Est. Return
R
Rebalance Palo Alto, California $1.91B AUM 16.23% 1-Year Est. Return
CCIA
Campbell & Co Investment Adviser Baltimore, Maryland $1.91B AUM 17.57% 1-Year Est. Return

Broadwood Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Broadwood Capital held 6 positions worth $548M, up 6.9% from $512M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2014: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 6-position portfolio largely intact.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 42% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Broadwood Capital added most to Lineage Cell Therapeutics in Q2 2014, an estimated $10.1M increase.
  • Broadwood Capital's biggest Q2 2014 reduction was QUESTCOR PHARMA INC, cutting an estimated $17.6M.
  • Broadwood Capital's ten largest holdings make up 100% of its $548M portfolio in Q2 2014.
  • Broadwood Capital opened 0 new positions and closed 0 in Q2 2014.
  • Broadwood Capital's portfolio value rose 6.9% quarter-over-quarter to $548M.

Based on Broadwood Capital's 13F filing for Q2 2014, filed 14 Aug 2014.